SLCTR/2013/036尚未招募未知
The effects of a herbal medicinal product, Swastha Thriphala, on the side effects of chemotherapy and radiotherapy in patients with cancer
ink Natural Products (Pvt) Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Consenting adults 20-70 years
- •2. With any diagnosed cancer
- •3. Receiving chemotherapy or radiotherapy (intervention will be given concomitantly with the chemotherapy/radiotherapy regimens) for cancer
- •4. Presenting to the Oncology Clinic Teaching Hospital Karapitiya, Galle.
排除标准
- •Patients with diagnosed
- •1. Heart failure
- •2. Chronic kidney diseases
- •3. Respiratory diseases
- •4. Chronic liver diseases
- •6. Dementia
- •7. Frailty
- •8. Parkinson disease
研究者
相似试验
已完成
不适用
The effects of Swastha Thriphala®, an Ayurveda medicinal formulation on blood lipidsHyperlipidaemiaSLCTR/2013/027ink Natural Products (Pvt) Ltd
已完成
3 期
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis mediaDRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
进行中（未招募）
不适用
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG
已完成
2 期
Herbal Drug for Treatment of Functional Dyspepsia and eradication of Helicobacter pylori(H.pylori) infection.Functional Dyspepsia.DyspepsiaIRCT20160721029026N4Hormozgan Science & Technology Park60
已完成
2 期
Herbal drug for treatment of Irritable bowel syndrome (IBS)Irritable bowel syndrome.Irritable bowel syndromeIRCT2016072629026N3Hormozgan Science & Technology Park60